News

Most recently, Greig has worked with GlaxoSmithKline’ (GSK) Corporate Venture Group, SR One. Greig has held senior leadership positions in GSK, Advanced Technologies, Rib-X Pharmaceuticals and Anaphore in

Aquinox Pharma’s Phase 1 AQX-1125 is a three part study in healthy volunteers. The primary objectives of Phase I are to evaluate the safety, tolerability and pharmacokinetics of

Under the agreement, Ranbaxy was expected to receive around $100m payment from the American drug company, Merck, Economic Times reported. Reportedly, Merck has transferred the research programs to

Rivaroxaban is an oral anticoagulant being evaluated for the prevention and treatment of a range of disorders in which blood clotting plays a major role. According to J&JPRD,

Previously, Teva Pharma has signed an agreement with Theramex to take over the distribution rights of Theramex’s products sold in Spain and Brazil and several other countries. Under

The companies said that the new collaboration will support the development program of therapies that caters to multiple rare diseases such as, lysosomal storage diseases (LSDs). Synageva R&D

Actemra includes labeling for inhibition and slowing of structural joint damage, improvement of physical function, and achievement of major clinical response in adult with moderately to severely active

The grant which is awarded under the Qualifying Therapeutic Discovery Project Program (QTDP) to Neogenix is totaled up to $733,437.74. The company’s NPC-1C (Ensituximab) monoclonal antibody is currently

GOLD provides evidence-based guidelines for COPD management and is updated annually by a committee of leading COPD experts. A section on the new class, phosphodiesterase 4 (PDE4) inhibitors,